These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 6653647

  • 21. Myocardial monovalent cation transport during the quinidine-digoxin interaction in dogs.
    Warner NJ, Barnard JT, Leahey EB, Hougen TJ, Bigger JT, Smith TW.
    Circ Res; 1984 Apr; 54(4):453-60. PubMed ID: 6713609
    [Abstract] [Full Text] [Related]

  • 22. Increase in serum digoxin concentration produced by quinidine does not increase the potential for digoxin-induced ventricular arrhythmias in dogs.
    Wilkerson RD, Beck BL.
    J Pharmacol Exp Ther; 1987 Feb; 240(2):548-53. PubMed ID: 3806410
    [Abstract] [Full Text] [Related]

  • 23. Lack of clinically relevant drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and verapamil, ramipril, or digoxin in healthy volunteers.
    Macha S, Sennewald R, Rose P, Schoene K, Pinnetti S, Woerle HJ, Broedl UC.
    Clin Ther; 2013 Mar; 35(3):226-35. PubMed ID: 23497760
    [Abstract] [Full Text] [Related]

  • 24. Alteration of digoxin pharmacokinetics by a single dose of quinidine.
    Chen TS, Friedman HS.
    JAMA; 1980 Aug 15; 244(7):669-72. PubMed ID: 6156244
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [The influence of quinidine on serum digoxin concentrations (author's transl)].
    Doering W, König E.
    Med Klin; 1978 Jul 28; 73(30):1085-8. PubMed ID: 672763
    [Abstract] [Full Text] [Related]

  • 28. Use of control steady-state serum digoxin levels for predicting serum digoxin concentration after quinidine administration.
    Friedman HS, Chen TS.
    Am Heart J; 1982 Jul 28; 104(1):72-6. PubMed ID: 6178280
    [Abstract] [Full Text] [Related]

  • 29. Quinidine-digoxin interaction: Pharmacokinetics, underlying mechanism and clinical implications.
    Doering W.
    N Engl J Med; 1979 Aug 23; 301(8):400-4. PubMed ID: 460341
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The influence of verapamil on serum digoxin concentration.
    Klein HO, Lang R, Weiss E, Di Segni E, Libhaber C, Guerrero J, Kaplinsky E.
    Circulation; 1982 May 23; 65(5):998-1003. PubMed ID: 7074765
    [Abstract] [Full Text] [Related]

  • 33. Interaction between quinidine and digoxin.
    Leahey EB, Reiffel JA, Drusin RE, Heissenbuttel RH, Lovejoy WP, Bigger JT.
    JAMA; 1978 Aug 11; 240(6):533-4. PubMed ID: 671662
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Stereoselective inhibition by the diastereomers quinidine and quinine of uptake of cardiac glycosides into isolated rat hepatocytes.
    Hedman A, Meijer DK.
    J Pharm Sci; 1998 Apr 11; 87(4):457-61. PubMed ID: 9548899
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Digoxin-quinidine-spironolactone interaction.
    Fenster PE, Hager WD, Goodman MM.
    Clin Pharmacol Ther; 1984 Jul 11; 36(1):70-3. PubMed ID: 6734052
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.